Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Richard Lalonde
Observed name:
R. T. LaLonde
Institution:
University of Florida
Observed institutions:
SUNY College of Environmental Science and Forestry,
Pfizer (United States),
University of Florida
OpenAlex ID:
A5111593466
Understanding Placebo Responses in Alzheimer's Disease Clinical Trials from the Literature Meta-Data and CAMD Database
2013
·
Kaori Ito
, Brian Corrigan
, et al.
·
Journal of Alzheimer s Disease
·
66
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop
2014
·
Klaus Romero
, Vikram Sinha
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
19
Population Pharmacokinetics of Clinafloxacin in Healthy Volunteers and Patients with Infections: Experience with Heterogeneous Pharmacokinetic Data
2001
·
Bill Frame
, Jeffrey Koup
, et al.
·
Clinical Pharmacokinetics
·
11
Structure of an anhydride related to a mutagenic component of drinking water, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone
1990
·
R. T. LaLonde
, H. Perakyla
, et al.
·
Chemical Research in Toxicology
·
7
How debunking biases in research and development decisions could lead to more equitable healthcare?
2024
·
Benjamin Weber
, Issam Zineh
, et al.
·
Clinical and Translational Science
·
5
PDF
S3‐02‐01: Quantifying the placebo effect through modeling and simulation
2015
·
Klaus Romero
, Kaori Ito
, et al.
·
Alzheimer s & Dementia
O4‐04‐08: A model‐based approach to understanding the natural history of cognitive change in treated and untreated Alzheimer's disease
2009
·
Brian Corrigan
, Kaori Ito
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
10
Citation count:
109
H-index:
5
I10-index:
3
Year
Topic
Type